Prosecution Insights
Prosecution Insights
164 pending office actions • 77 art units • 155 examiners • 0 of 164 (0%) have an AI response strategy ready • 120 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 71 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 71 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 2 (1%) |
| §101 + other | 22 (13%) |
| §103 only | 39 (24%) |
| §102 only | 3 (2%) |
| §112 only | 12 (7%) |
| Double-patenting only | 5 (3%) |
| Double-patenting + other | 12 (7%) |
| Multi-statute (no §101) | 69 (42%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KENNEDY, SARAH JANE | 2 | 0.0% | +0.0% |
| CHERNYSHEV, OLGA N | 2 | 54.5% | +34.2% |
| REYNOLDS, FRED H | 2 | 33.1% | +39.0% |
| GRAY, JESSICA | 2 | 0.0% | +0.0% |
| HOWARD, ZACHARY C | 2 | 63.8% | +38.0% |
| HONRATH, MARC D | 2 | 74.1% | +31.0% |
| KASSA, TIGABU | 2 | 36.5% | +28.2% |
| DENT, ALANA HARRIS | 2 | 44.3% | +32.1% |
| HANEY, AMANDA MARIE | 2 | 36.5% | +44.5% |
| HANNAN, B M M | 1 | 82.2% | +17.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16763827 | COMPOSITIONS AND METHODS FOR EFFICIENT GENOME EDITING | WHITEMAN, BRIAN A | 146d overdue |
| 18030465 | DETECTION OF ACE2 IgM AUTOANTIBODIES AS MARKERS OF SEVERITY AND MECHANISM IN COVID19 PATIENTS | GILL, RACHEL B | 124d overdue |
| 18850458 | Leg Support for Orthopaedic Surgery | RODRIQUEZ, KARI KRISTIN | 104d overdue |
| 18698097 | AUTOMATIC RADIOTHERAPY PRESCRIPTION ANOMALY DETECTION | COBANOGLU, DILEK B | 56d overdue |
| 18441540 | System And Method For Displaying An Image | SHAFQAT, AMY JEANETTE | 52d overdue |
| 18284131 | METHODS OF DETERMINING TREATMENT OUTCOME | GRAY, JESSICA | 31d overdue |
| 18259345 | ACOUSTEOMIC SENSING AND MONITORING USING A HUMAN-CENTRIC INTELLIGENT ACOUSTEOMIC ARRAY | WU, TONG E | 31d overdue |
| 18351087 | HLA-RESTRICTED EPITOPES ENCODED BY SOMATICALLY MUTATED GENES | DIBRINO, MARIANNE | 24d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16809496 | METHOD OF IDENTIFYING RISK FOR AUTISM | HANEY, AMANDA MARIE | 31d overdue |
| 18657340 | CITRULLINATED BRAIN AND NEUROLOGICAL PROTEINS AS BIOMARKERS OF BRAIN INJURY OR NEURODEGENERATION | CHERNYSHEV, OLGA N | 8d overdue |
| 18253231 | PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA)-TARGETED PRODRUG FOR SELECTIVE KILLING OF CELLS EXPRESSING PSMA | REYNOLDS, FRED H | 60d |
| 18315330 | BIOMIMETIC ARTIFICIAL CELLS: ANISOTROPIC SUPPORTED LIPID BILAYERS ON BIODEGRADABLE MICRO AND NANOPARTICLES FOR SPATIALLY DYNAMIC SURFACE BIOMOLECULE PRESENTATION | KASSA, TIGABU | 70d |
| 17047006 | NON-INVASIVE DETECTION OF RESPONSE TO IMMUNOTHERAPY | HANEY, AMANDA MARIE | 72d |
| 18187526 | CHEMICAL COMPOSITION | KASSA, TIGABU | 84d |
| 19238047 | ROBOTIC TASK COMPLETION FROM NATURAL LANGUAGE REQUESTS | HANNAN, B M M | — |
| 18557801 | CYCLIC PEPTIDE INHIBITORS OF USP22 | REYNOLDS, FRED H | — |
| Art Unit | Apps |
|---|---|
| 1682 | 8 |
| 1618 | 8 |
| 3791 | 7 |
| 3798 | 6 |
| 1619 | 5 |
| 1675 | 5 |
| 3797 | 4 |
| 1658 | 4 |
| 1626 | 3 |
| 1614 | 3 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19238047 | ROBOTIC TASK COMPLETION FROM NATURAL LANGUAGE REQUESTS | HANNAN, B M M | 3657 | §101§112 | Non-Final OA | — | Pending | Jun 13, 2025 |
| 19209076 | LINEAR BEARING CLUTCH TOGGLE | LORENCE, RICHARD M | 3617 | §102 | Non-Final OA | — | Pending | May 15, 2025 |
| 19174285 | NEUROMODULATION BASED NERVE IDENTIFICATION | MATTSON, SEAN D | 3798 | §103§112Other | Non-Final OA | 36d | Pending | Apr 09, 2025 |
| 18980807 | OFFSET ILLUMINATION CAPILLAROSCOPE | TON, TRI T | — | §103Other | Non-Final OA | — | Pending | Dec 13, 2024 |
| 18972277 | IN SITU NUCLEIC ACID ANALYSIS USING PROBE PAIR LIGATION | KENNEDY, SARAH JANE | 1682 | §112 | Final Rejection | — | Pending | Dec 06, 2024 |
| 18855172 | INTERACTIVE TOOL TO IMPROVE RISK PREDICTION AND CLINICAL CARE FOR A DISEASE THAT AFFECTS MULTIPLE ORGANS | EVANS, TRISTAN ISAAC | 3683 | §101§112 | Final Rejection | — | Pending | Oct 08, 2024 |
| 18850458 | Leg Support for Orthopaedic Surgery | RODRIQUEZ, KARI KRISTIN | 3786 | §102§112 | Final Rejection | 104d overdue | Pending | Sep 24, 2024 |
| 18839298 | REGISTRATION OF DEFORMABLE STRUCTURES | SOFRONIOU, MICHAEL MARIO | 2661 | §103§112 | Non-Final OA | — | Pending | Aug 16, 2024 |
| 18836900 | SYSTEMS AND METHODS FOR AUTOMATIC DETECTION AND LOCALIZATION OF FOREIGN BODY OBJECTS | BEGEMAN, ANDREW W | 3798 | §103 | Non-Final OA | 33d | Pending | Aug 08, 2024 |
| 18834007 | ORBITAL RESILIENT BLOCKCHAIN-ENABLED INTER-AGENT TRANSACTION SERVICE PROTOCOL | NARRAMORE, BLAKE I | 2438 | §103 | Final Rejection | — | Pending | Jul 29, 2024 |
| 18777197 | METHODS AND RELATED ASPECTS FOR PATHOLOGY PROGNOSIS | HUYNH, VAN D | 2665 | §103Other | Non-Final OA | — | Pending | Jul 18, 2024 |
| 18773723 | SUBMERSIBLE VEHICLE WITH A FLOODABLE ACTUATOR VESSEL | FIGUEROA, MICHAEL KENN POTICANO | — | §103 | Non-Final OA | — | Pending | Jul 16, 2024 |
| 18756960 | ITRACONAZOLE ANALOGS AND USE THEREOF | RAO, PADMAJA S | — | §102§103§112Other | Non-Final OA | — | Pending | Jun 27, 2024 |
| 18754996 | SYNTHESIS OF THE RADIOLABELED PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) INHIBITOR [18F]DCFPYL | SAMALA, JAGADISHWAR RAO | 1618 | §101§102§103DP | Non-Final OA | — | Pending | Jun 26, 2024 |
| 18715998 | METHODS AND RELATED ASPECTS FOR MITIGATING UNKNOWN BIASES IN COMPUTED TOMOGRAPHY DATA | BEKELE, MEKONEN T | 2699 | §102§103 | Non-Final OA | — | Pending | Jun 03, 2024 |
| 18670928 | NANOFIBER-HYDROGEL COMPOSITES FOR ENHANCED SOFT TISSUE REPLACEMENT AND REGENERATION | WRIGHT, SARAH C | 1619 | §112 | Non-Final OA | — | Pending | May 22, 2024 |
| 18657340 | CITRULLINATED BRAIN AND NEUROLOGICAL PROTEINS AS BIOMARKERS OF BRAIN INJURY OR NEURODEGENERATION | CHERNYSHEV, OLGA N | 1675 | DP | Non-Final OA | 8d overdue | Pending | May 07, 2024 |
| 18630226 | SURFACE-FORMED FIDUCIAL MARKERS AND SURGICAL OBJECT TRACKING | SILVA-AVINA, EMMANUEL | — | §102§103 | Non-Final OA | — | Pending | Apr 09, 2024 |
| 18698097 | AUTOMATIC RADIOTHERAPY PRESCRIPTION ANOMALY DETECTION | COBANOGLU, DILEK B | 3687 | §101§102 | Non-Final OA | 56d overdue | Pending | Apr 03, 2024 |
| 18694612 | AUTOMATED IDENTIFICATION OF HYPERINTENSIVE APPARENT DIFFUSION COEFFICIENT CLUSTERS FOR MRI-GUIDED LASER INTERSTITIAL THERMAL THERAPY | POPESCU, GABRIEL VICTOR | 3797 | §101§103 | Non-Final OA | 1d overdue | Pending | Mar 22, 2024 |
| 18693749 | BIOPSY NEEDLE ACCESSORY | KRETZER, KYLE W. | 3791 | §102§103§112 | Non-Final OA | 19d overdue | Pending | Mar 20, 2024 |
| 18693636 | MRNA REGULON THERAPY FOR THE TREATMENT OF HAPLOINSUFFICIENCY DISORDERS | GROOMS, TIFFANY NICOLE | — | §103 | Non-Final OA | — | Pending | Mar 20, 2024 |
| 18691585 | ACOUSTIC FREQUENCY ATLAS-BASED APPROACH FOR PHOTOACOUSTIC IDENTIFICATION OF SURGICAL BIOMARKERS | DEVITO, ALEX T | 2855 | §102§103§112 | Final Rejection | 11d overdue | Pending | Mar 13, 2024 |
| 18690782 | SYSTEM AND METHOD FOR REMOVING STIMULATION ARTIFACT IN NEUROMODULATION SYSTEMS | CIRULNICK, EMILY NICOLE | 3792 | §101§103Other | Final Rejection | 15d overdue | Pending | Mar 11, 2024 |
| 18591714 | SYSTEMS AND METHODS OF THERMOCHEMICALLY REDUCING METALLIC ELEMENTS USING THERMAL SHOCK | WANG, NICHOLAS A | — | §103 | Non-Final OA | — | Pending | Feb 29, 2024 |
| 18685691 | APPARATUS FOR AUTOMATED BLOOD PRESSURE MONITORING USING ULTRASOUND AND METHODS THEREOF | LAMPRECHT, JOEL | 3798 | §102§103 | Non-Final OA | — | Pending | Feb 22, 2024 |
| 18581931 | AUTOIMMUNE ANTIBODIES FOR USE IN INHIBITING CANCER CELL GROWTH | WEIDNER, ADAM M | — | §112 | Non-Final OA | — | Pending | Feb 20, 2024 |
| 18684083 | POLYMERS AND NANOPARTICLES FOR INTRAMUSCULAR NUCLEIC ACID DELIVERY | STEINKE, SEAN JAMES | 1619 | §102§103§112Other | Non-Final OA | — | Pending | Feb 15, 2024 |
| 18441540 | System And Method For Displaying An Image | SHAFQAT, AMY JEANETTE | 3798 | §103§112 | Non-Final OA | 52d overdue | Pending | Feb 14, 2024 |
| 18294646 | AGENTS, COMPOSITIONS, AND METHODS FOR CANCER DETECTION | LEWOCZKO, EVAN MICHAEL | — | §103 | Non-Final OA | — | Pending | Feb 02, 2024 |
| 18293683 | INHIBITORS OF HYPOXIA-INDUCIBLE FACTORS | CHAO, ALLEN | 1622 | §102§112 | Non-Final OA | — | Pending | Jan 30, 2024 |
| 18420857 | METHOD AND APPARATUS FOR PERFORMING MACHINE LEARNING ENRICHED NON-DESTRUCTIVE EVALUATION | DUONG, JOHNNYKHOI BAO | 2667 | §102§103 | Non-Final OA | — | Pending | Jan 24, 2024 |
| 18411753 | METHODS FOR PREVENTING OR SLOWING THE PROGRESSION OF COGNITIVE DECLINE OR IMPAIRMENT IN SUBJECTS | KUCKLA, ANNA GRACE | 1626 | §102§103§112Other | Non-Final OA | 35d | Pending | Jan 12, 2024 |
| 18535180 | NONVIRAL GENE TRANSFER TO THE SUPRACHOROIDAL SPACE | BASQUILL, SEAN M | 1614 | §103DP | Non-Final OA | — | Pending | Dec 11, 2023 |
| 18566938 | SYSTEM AND METHOD FOR DETECTING VULNERABILITIES IN OBJECT-ORIENTED PROGRAM CODE USING AN OBJECT PROPERTY GRAPH | HAJIABBASI, AMIR MAHDI | 2407 | §103 | Non-Final OA | — | Pending | Dec 04, 2023 |
| 18037482 | IMMUNO-ONCOLOGY TARGETS TO IMPROVE T-CELL METABOLIC RESPONSE | LOCKARD, JON MCCLELLAND | — | §112 | Non-Final OA | — | Pending | Nov 17, 2023 |
| 18289332 | AUTOANTIBODIES FOR USE IN IDENTIFYING DISEASE | BAUSCH, SARAE L | 1699 | §101§102§103§112 | Non-Final OA | — | Pending | Nov 02, 2023 |
| 18557801 | CYCLIC PEPTIDE INHIBITORS OF USP22 | REYNOLDS, FRED H | 1658 | §101§102§112 | Non-Final OA | — | Pending | Oct 27, 2023 |
| 18288252 | ESOPHAGEAL SLEEVE DEVICES AND METHODS OF MAKING THE SAME | WOZNICKI, JACQUELINE | 3774 | §102§103§112 | Non-Final OA | 18d overdue | Pending | Oct 25, 2023 |
| 18556964 | SEQUENTIAL HORMONE THERAPY TO IMPROVE SURVIVAL AND ENHANCE RESPONSE TO IMMUNE THERAPY IN MEN WITH PROSTATE CANCER | TRAN, ERIC | 1629 | §103 | Final Rejection | — | Pending | Oct 24, 2023 |
| 18556244 | A Gastrojejunostomy Tube Enabling Bedside Exchange Without Radiation, Sedation, or Procedure Room Time | HARRIS, WESLEY G | 3783 | §102§103§112 | Non-Final OA | 22d | Pending | Oct 19, 2023 |
| 18380984 | NanoMesh Drug Delivery for Treatment of Brain Tumors | KIM, DANIELLE A | 1613 | §103 | Non-Final OA | 25d overdue | Pending | Oct 17, 2023 |
| 18554928 | OPHTHALMIC FORMULATIONS FOR SUSTAINED NEUROPROTECTION | BARBER, KIMBERLY | 1626 | §103 | Non-Final OA | — | Pending | Oct 11, 2023 |
| 18484137 | ENGINEERED VASCULAR TISSUE MODELS | SCHUBERG, LAURA J | 1631 | §103DP | Non-Final OA | 43d | Pending | Oct 10, 2023 |
| 18484167 | SURGICAL INSTRUMENT | FERNSTROM, KURT | 3715 | DP | Final Rejection | — | Pending | Oct 10, 2023 |
| 18553785 | SURFACE ENHANCED RAMAN SPECTROSCOPY METHOD OF PATHOGEN DETECTION AND SUBSTRATE FOR THE SAME | PHILLIPS, RUFUS L | 2877 | §103 | Final Rejection | — | Pending | Oct 03, 2023 |
| 18477878 | CASPASE INHIBITION TO ENHANCE REGENERATION AND REPAIR AFTER SKIN OR GUT INJURY AND TO TREAT BACTERIAL OR VIRAL INFECTIONS | HA, JULIE | 1654 | §102§103§112 | Non-Final OA | — | Pending | Sep 29, 2023 |
| 18284131 | METHODS OF DETERMINING TREATMENT OUTCOME | GRAY, JESSICA | 1682 | §101§102§103§112 | Final Rejection | 31d overdue | Pending | Sep 26, 2023 |
| 18283887 | METHODS AND MATERIALS FOR TARGETING TUMOR ANTIGENS | HOWARD, ZACHARY C | 1674 | §102§112 | Non-Final OA | — | Pending | Sep 25, 2023 |
| 18281471 | ENGINEERED IMMUNE CELLS AND USES THEREOF | JUEDES, AMY E | 1644 | §102§103§112 | Non-Final OA | — | Pending | Sep 11, 2023 |
| 18548767 | DETECTION OF STAGE I LUNG CANCER BIOMARKERS | AGAHI, PUYA | 3791 | §101§103 | Final Rejection | 75d | Pending | Sep 01, 2023 |
| 18548423 | ANTI-FIBROTIC THERAPIES | HEASLEY, MEGHAN CHRISTINE | 1626 | §103§112Other | Non-Final OA | 42d | Pending | Aug 30, 2023 |
| 18237744 | NANOFIBER-HYDROGEL COMPOSITES FOR CELL AND TISSUE DELIVERY | MOSS, NATALIE M | 1653 | §103§112 | Non-Final OA | — | Pending | Aug 24, 2023 |
| 18546221 | METHODS FOR PREPARATION OF PLASMID DNA/LIPID PARTICLES WITH DEFINED SIZE FOR IN VITRO AND IN VIVO TRANSFECTION | MOORE, JOHN DAVID | 1638 | §103§112 | Non-Final OA | 8d overdue | Pending | Aug 11, 2023 |
| 18263644 | SMART PILL DISPENSER | OJOFEITIMI, AYODEJI T | 3651 | §102§103 | Final Rejection | 5d | Pending | Jul 31, 2023 |
| 18274560 | METHODS FOR INHIBITING CORONAVIRUSES USING SULFORAPHANE | JOHNSON, CHRISTOPHER LINDSAY | 1691 | §103 | Non-Final OA | 22d | Pending | Jul 27, 2023 |
| 18274133 | PHOTO-CROSSLINKED BIOREDUCIBLE POLYMERIC NANOPARTICLES FOR ENHANCED RNA DELIVERY | POPA, ILEANA | 1633 | §103§112 | Non-Final OA | 3d overdue | Pending | Jul 25, 2023 |
| 18262536 | PATIENT-SPECIFIC BRACHYTHERAPY APPLICATORS | HONRATH, MARC D | 3791 | §102§103§112 | Non-Final OA | — | Pending | Jul 21, 2023 |
| 18224156 | CHECKPOINT BLOCKADE AND MICROSATELLITE INSTABILITY | COOK, LISA V | 1642 | DP | Non-Final OA | — | Pending | Jul 20, 2023 |
| 18224151 | WEARABLE SYSTEM FOR MUSCLE ACTIVITY SENSING AND FEEDBACK | ANTISKAY, BRIAN MICHAEL | 3794 | §103§112 | Final Rejection | 85d | Pending | Jul 20, 2023 |
| 18223331 | MULTI-IMAGER COMPATIBLE ROBOT FOR IMAGE-GUIDED INTERVENTIONS AND FULLY AUTOMATED BRACHYTHERAPY SEED | HONRATH, MARC D | 3791 | §103§112 | Final Rejection | — | Pending | Jul 18, 2023 |
| 18351087 | HLA-RESTRICTED EPITOPES ENCODED BY SOMATICALLY MUTATED GENES | DIBRINO, MARIANNE | 1641 | §102§103§112Other | Non-Final OA | 24d overdue | Pending | Jul 12, 2023 |
| 18259345 | ACOUSTEOMIC SENSING AND MONITORING USING A HUMAN-CENTRIC INTELLIGENT ACOUSTEOMIC ARRAY | WU, TONG E | 3796 | §102§103§112 | Non-Final OA | 31d overdue | Pending | Jun 26, 2023 |
| 18268893 | DETECTION OF LUNG CANCER USING CELL-FREE DNA FRAGMENTATION | GRAY, JESSICA | 1682 | §101§103§112Other | Final Rejection | 18d overdue | Pending | Jun 21, 2023 |
| 18257925 | METHODS, SYSTEMS AND RELATED ASPECTS FOR REAL-TIME PREDICTION OF ADVERSE OUTCOMES USING MACHINE LEARNING AND HIGH-DIMENSIONAL CLINICAL DATA | VANNI, GEORGE STEVEN | — | §101§103§112 | Non-Final OA | — | Pending | Jun 16, 2023 |
| 18256326 | METHODS OF NK CELL ENGINEERING TO ENHANCE TUMOR TARGETING | YOUTCHOM PENDIE, EMMANUEL LED | 1647 | §102§103 | Non-Final OA | — | Pending | Jun 07, 2023 |
| 18265118 | SIGNAL | STUBBS, JOHN THOMAS | — | §101§103§112 | Non-Final OA | — | Pending | Jun 02, 2023 |
| 18255769 | POLYMERIC NANOPARTICLE COMPOSITIONS FOR ENCAPSULATION AND SUSTAINED RELEASE OF NEUROMODULATORS | JACKSON-TONGUE, LAKIA J | 1645 | §103 | Final Rejection | — | Pending | Jun 02, 2023 |
| 18255630 | RADIOMICS STANDARDIZATION | ZHANG, FAN | 2682 | §103 | Non-Final OA | — | Pending | Jun 02, 2023 |
| 18255518 | RESTORATION OF MOTOR FUNCTION POST-NEUROLOGICAL INJURY USING PSYCHEDELICS | SIMMONS, CHRIS E | 1622 | §103 | Non-Final OA | — | Pending | Jun 01, 2023 |
| 18039403 | METHODS AND MATERIALS FOR TREATING T CELL CANCERS | MACFARLANE, STACEY NEE | 1675 | §112Other | Non-Final OA | — | Pending | May 30, 2023 |
| 18202066 | MAP KINASE PATHWAY TARGETS FOR THE TREATMENT OF MARFAN SYNDROME | HAM, JIEUN | 1643 | §102§103§112 | Non-Final OA | 15d overdue | Pending | May 25, 2023 |
| 18322237 | SYSTEMS AND METHODS FOR SAFE AND FLEXIBLE BATTERIES | BILLIET, AMANDA JUNE | 1729 | §112 | Non-Final OA | — | Pending | May 23, 2023 |
| 18037508 | INTEGRATED ROBOTIC INTRAOCULAR SNAKE | HUSSAINI, ATTIYA SAYYADA | 3792 | §103§112 | Final Rejection | — | Pending | May 17, 2023 |
| 18253231 | PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA)-TARGETED PRODRUG FOR SELECTIVE KILLING OF CELLS EXPRESSING PSMA | REYNOLDS, FRED H | 1658 | §102§103§112DPOther | Non-Final OA | 60d | Pending | May 17, 2023 |
| 18315330 | BIOMIMETIC ARTIFICIAL CELLS: ANISOTROPIC SUPPORTED LIPID BILAYERS ON BIODEGRADABLE MICRO AND NANOPARTICLES FOR SPATIALLY DYNAMIC SURFACE BIOMOLECULE PRESENTATION | KASSA, TIGABU | 1619 | §103 | Final Rejection | 70d | Pending | May 10, 2023 |
| 18036022 | METHODS FOR INHIBITING CHMP7 EXPRESSION IN NEURONAL CELLS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS | HUDSON, AMY ROSE | 1636 | §101§102§103§112 | Non-Final OA | — | Pending | May 09, 2023 |
| 18312116 | MARKER FOR IDENTIFYING SURGICAL CAVITY IN TARGETED RADIATION | CHOI, YOUNHEE JEON | 3797 | §103§112 | Non-Final OA | — | Pending | May 04, 2023 |
| 18306872 | NON-LINEAR MULTIBLOCK COPOLYMER-DRUG CONJUGATES FOR THE DELIVERY OF ACTIVE AGENTS | PIPIC, ALMA | 1617 | DP | Final Rejection | — | Pending | Apr 25, 2023 |
| 18033746 | COMPOSITIONS AND METHODS FOR TREATING DISORDERS CHARACTERIZED WITH TGF-BETA ACTIVITY | HOWARD, ZACHARY C | 1674 | §103§112 | Non-Final OA | — | Pending | Apr 25, 2023 |
| 18249676 | INTRINSICALLY-DISORDERED PROTEINS AS EMULSIFIERS | KNIGHT, SAMANTHA JO | 1614 | §103§112 | Final Rejection | 15d | Pending | Apr 19, 2023 |
| 18248722 | ASSESSING A CARDIAC CONDITION INDEPENDENTLY OF PPG WAVEFORM AMPLITUDE ANALYSIS | WEARE, MEREDITH H | 3791 | §101§103 | Non-Final OA | 60d | Pending | Apr 12, 2023 |
| 18030465 | DETECTION OF ACE2 IgM AUTOANTIBODIES AS MARKERS OF SEVERITY AND MECHANISM IN COVID19 PATIENTS | GILL, RACHEL B | 1671 | §101§103 | Non-Final OA | 124d overdue | Pending | Apr 05, 2023 |
| 18247697 | SYSTEMS AND METHODS FOR MONITORING AND TREATMENT OF AN INJURY | BROWN, HELENE CATHERINE | 3797 | §103 | Final Rejection | — | Pending | Apr 03, 2023 |
| 18194840 | HYPOTONIC MICROBICIDAL FORMULATIONS AND METHODS OF USE | KUCHARCZK, JED A | 1623 | §102§103§112DP | Final Rejection | — | Pending | Apr 03, 2023 |
| 18247144 | INTEGRATED PROTEOMIC BIOMARKERS FOR THE DETECTION OF AGGRESSIVE PROSTATE CANCER | DENT, ALANA HARRIS | 1643 | §103§112 | Non-Final OA | — | Pending | Mar 29, 2023 |
| 18246063 | POLYMERS AND NANOPARTICLE FORMULATIONS FOR SYSTEMIC NUCLEIC ACID DELIVERY | NIEBAUER, RONALD T | 1658 | §102§103§112Other | Non-Final OA | 3d overdue | Pending | Mar 21, 2023 |
| 18187526 | CHEMICAL COMPOSITION | KASSA, TIGABU | 1619 | §103§112 | Non-Final OA | 84d | Pending | Mar 21, 2023 |
| 18027067 | NUCLEIC ACID DETECTION USING A NUCLEASE ACTUATOR | SALVOZA, M FRANCO G | 1672 | §103§112 | Non-Final OA | 84d | Pending | Mar 17, 2023 |
| 18167546 | IMPLANTABLE LENS CAPSULE FOR INTRAOCULAR LENS INSERTION | LOPEZ, LESLIE ANN | 3774 | §102§103 | Non-Final OA | — | Pending | Feb 10, 2023 |
| 18015684 | COMPREHENSIVE ANALYSIS OF ANTI-ALLERGEN ANTIBODIES USING PHAGE DISPLAY | ROONEY, NORA MAUREEN | 1641 | §102§103 | Non-Final OA | — | Pending | Jan 11, 2023 |
| 18004966 | SYSTEM AND METHOD FOR DETERMINING AN AUSCULTATION QUALITY METRIC | STEAR, RYAN JAMES | 2857 | §101§103 | Final Rejection | — | Pending | Jan 10, 2023 |
| 18013864 | METHODS TO GLYCOENGINEER PROTEINS | DAHLE, CHUN WU | 1641 | §102§112 | Final Rejection | 63d | Pending | Dec 29, 2022 |
| 18003462 | GROWTH AND SITE-SPECIFIC ORGANIZATION OF MICRO-SCALE BIMOLECULAR DEVICES ON LIVING CELLS | ROSSI, JULIA ANNE LORRAIN | 1615 | §103§112 | Final Rejection | 14d | Pending | Dec 27, 2022 |
| 18011070 | ADAPTIVE NANOPARTICLE PLATFORMS FOR HIGH THROUGHPUT EXPANSION AND DETECTION OF ANTIGEN-SPECIFIC T CELLS | KIM, TAEYOON | 1631 | §102§103DP | Final Rejection | — | Pending | Dec 16, 2022 |
| 18011071 | NON-INTUITIVE COMBINATION OF DRUG DELIVERY CARRIERS OF THE SAME DRUG FOR SYNERGISTIC GROWTH DELAY OF SOLID TUMORS | YOUNG, MICAH PAUL | 1618 | §103 | Final Rejection | — | Pending | Dec 16, 2022 |
| 18001992 | METHODS AND RELATED ASPECTS FOR OCULAR PATHOLOGY DETECTION | WILLIAMS, REBECCA COLETTE | 2677 | §103 | Non-Final OA | — | Pending | Dec 15, 2022 |
| 17993179 | SLEEP ASSESSMENT AND STIMULUS APPARATUS AND METHODS | DIETZ, NOE ROBERT | 3791 | §103 | Final Rejection | — | Pending | Nov 23, 2022 |
| 17998839 | FUNCTIONAL SKIN COATING POLYMER | BABSON, NICOLE PLOURDE | 1619 | §103§112 | Final Rejection | — | Pending | Nov 15, 2022 |
| 18052804 | PSMA-TARGETING COMPOUNDS AND USES THEREOF | PERREIRA, MELISSA JEAN | 1618 | DP | Non-Final OA | — | Pending | Nov 04, 2022 |
| 17922662 | COMPOSITIONS AND METHODS FOR CORONAVIRUS DETECTION | KINSEY WHITE, NICOLE ERIN | 1672 | §112 | Non-Final OA | — | Pending | Nov 01, 2022 |
| 18050809 | PAPANICOLAOU TEST FOR OVARIAN AND ENDOMETRIAL CANCERS | SCHLOOP, ALLISON ELIZABETH | 1683 | §103DP | Non-Final OA | — | Pending | Oct 28, 2022 |
| 17973887 | EFFUSION CELL FOR OUTGASSING MEASUREMENTS | SHABMAN, MARK A | 2855 | §102§103§112 | Non-Final OA | 5d | Pending | Oct 26, 2022 |
| 17995455 | METHODS AND RELATED ASPECTS FOR EAR PATHOLOGY DETECTION | WOO, JAE KYUN | 3795 | §103 | Non-Final OA | — | Pending | Oct 04, 2022 |
| 17995148 | GUIDANCE OF ARRHYTHMIA ABLATION USING A PATIENT'S HEART DIGITAL TWIN | MAPAR, BIJAN | 2189 | §101§103§112 | Non-Final OA | — | Pending | Sep 30, 2022 |
| 17934937 | COMPOSITIONS AND METHODS FOR TREATING DISORDERS CHARACTERIZED WITH EXCESSIVE OSTEOCLAST ACTIVITY | HAMA, JOANNE | 1647 | §103§112 | Non-Final OA | — | Pending | Sep 23, 2022 |
| 17947661 | METHOD AND SYSTEM FOR MONITORING CORNEAL TISSUE HEALTH | DINH, JACK | 2872 | §103 | Final Rejection | — | Pending | Sep 19, 2022 |
| 17800838 | SUPRACHOROIDAL DELIVERY OF DRUG PARTICLES TO REDUCE TOXICITY | FAY, ZOHREH ALEMZADEH | 1617 | §103 | Final Rejection | 20d | Pending | Aug 18, 2022 |
| 17797676 | CANCER IMMUNOTHERAPY USING TRANSFUSIONS OF ALLOGENEIC, TUMOR-SPECIFIC CD4+ T CELLS | DENT, ALANA HARRIS | 1643 | §102 | Final Rejection | — | Pending | Aug 04, 2022 |
| 17873980 | IN SITU FORMING COMPOSITE MATERIAL FOR TISSUE RESTORATION | JONES, DAMERON LEVEST | 1618 | §103§112Other | Non-Final OA | — | Pending | Jul 26, 2022 |
| 17792477 | ENGINEERED FIBROBLASTS AS CELL THERAPY TO TREAT CANCER VIA TUMOR STROMA STABILIZATION | TIWARI, VYOMA SHUBHAM | 1634 | §112 | Non-Final OA | — | Pending | Jul 13, 2022 |
| 17790293 | IN SITU RNA ANALYSIS USING PROBE PAIR LIGATION | KENNEDY, SARAH JANE | 1682 | DPOther | Final Rejection | 72d | Pending | Jun 30, 2022 |
| 17789099 | ENHANCING EXPRESSION OF LINE-1 ENCODED ORF2P FOR CANCER THERAPEUTICS | BEANE, RANDALL L | 1654 | §103§112 | Final Rejection | 3d overdue | Pending | Jun 24, 2022 |
| 17842893 | CELL-FREE DNA FOR ASSESSING AND/OR TREATING CANCER | MINCHELLA, KAITLYN L | 1685 | §101§103§112DP | Non-Final OA | — | Pending | Jun 17, 2022 |
| 17840666 | REMEDIATION OF PER- AND POLYFLUOROALKYL CONTAMINATED MATERIALS | SHERMAN, ERIC SCOTT | 1736 | §102§103 | Non-Final OA | 15d | Pending | Jun 15, 2022 |
| 17782742 | COMPANION DIAGNOSTICS FOR COMPLEMENT INHIBITORS | LUSI, ELLIS FOLLETT | 1677 | §101§103§112 | Final Rejection | 23d | Pending | Jun 06, 2022 |
| 17771142 | POLYMERIC NANOPARTICLES FOR INTRACELLULAR PROTEIN DELIVERY | ROGERS, JAMES WILLIAM | 1618 | §102§103§112 | Final Rejection | 57d | Pending | Apr 22, 2022 |
| 17770531 | A CRISPR-CAS9 PLATFORM WITH AN INTRINSIC OFF-SWITCH AND ENHANCED SPECIFICITY | REGA, KYLE THOMAS | 1636 | §103 | Final Rejection | — | Pending | Apr 20, 2022 |
| 17770437 | MUCUS PENETRATING PARTICLE COMPOSITIONS AND METHODS OF USE THEREOF ENHANCING IMMUNE RESPONSE | CRAIGO, WILLIAM A | 1615 | §103§112 | Non-Final OA | — | Pending | Apr 20, 2022 |
| 17769960 | ASSAY FOR RAPID EVALUATION OF CHOROIDAL MAST CELL DEGRANULATION | MEJIAS, SAMANTHA LEE | 1618 | §102§103 | Non-Final OA | 28d | Pending | Apr 18, 2022 |
| 17768591 | COMPOSITIONS AND METHODS FOR USING ALTERNATIVE SPLICING TO CONTROL SPECIFICITY OF GENE THERAPY | MARVICH, MARIA | 1634 | §102§112 | Final Rejection | — | Pending | Apr 13, 2022 |
| 17767389 | HIGHLY MULTIPLEXED DETECTION OF NUCLEIC ACIDS | ALAM, DANYAL HASSAN | 1600 | §103§112DP | Final Rejection | — | Pending | Apr 07, 2022 |
| 17715435 | DRUG DELIVERY SYSTEMS AND TARGETED RELEASE OF PHARMACEUTICAL AGENTS WITH FOCUSED ULTRASOUND | LIU, TRACY | 1614 | §103 | Final Rejection | 9d | Pending | Apr 07, 2022 |
| 17763909 | NOVEL COMPOSITIONS AND METHODS FOR BONE GRAFTS AND FUSIONS | ALAM, AYAAN A | 1611 | §103§112 | Final Rejection | — | Pending | Mar 25, 2022 |
| 17642284 | CRANIAL IMPLANT DEVICES AND RELATED METHODS FOR MONITORING BIOMETRIC DATA | BERHANU, ETSUB D | 3791 | §112 | Final Rejection | — | Pending | Mar 11, 2022 |
| 17633917 | BIOMARKERS FOR NEURODEGENERATIVE DISORDERS | FRITCHMAN, REBECCA M | 1758 | §103 | Non-Final OA | 2d overdue | Pending | Feb 08, 2022 |
| 17576503 | ASSAYING OVARIAN CYST FLUID | JOHANNSEN, DIANA B | 1682 | §102§103 | Final Rejection | — | Pending | Jan 14, 2022 |
| 17624440 | IMMOBILIZATION AND QUANTITATIVE MEASUREMENT OF DROPLETS | KRCHA, MATTHEW D | 1796 | §102 | Final Rejection | — | Pending | Jan 03, 2022 |
| 17623060 | COMPOSITIONS AND METHODS OF TREATING LIVER CANCERS | NESTOR, DONNA MICHELLE | 1627 | §103 | Final Rejection | 107d overdue | Pending | Dec 27, 2021 |
| 17622504 | METHODS AND MATERIALS FOR TARGETED EXPANSION OF REGULATORY T CELLS | PATTERSON, SARAH COOPER | 1675 | §103§112 | Final Rejection | 19d overdue | Pending | Dec 23, 2021 |
| 17616740 | DETERMINING CAUSES OF DISEASES SUCH AS CANCER, USING MACHINE LEARNING ANALYSIS OF GENETIC DATA | HAYES, JONATHAN EDWARD | 1685 | §101 | Final Rejection | 22d | Pending | Dec 06, 2021 |
| 17606605 | COMPOSITIONALLY DEFINED PLASMID DNA/POLYCATION NANOPARTICLES AND METHODS FOR MAKING THE SAME | DUNSTON, JENNIFER ANN | 1637 | §102§103DP | Final Rejection | — | Pending | Oct 26, 2021 |
| 17600843 | LIPID NANOPARTICLES AS ORAL VEHICLES OF IMMUNOTHERAPY | HOERNER, PAUL ELLSWORTH | 1611 | §103§112 | Final Rejection | — | Pending | Oct 01, 2021 |
| 17598690 | METHODS AND MATERIALS FOR ASSESSING AND TREATING CANCER | LU, CHENG | 1642 | §102§103§112DP | Non-Final OA | — | Pending | Sep 27, 2021 |
| 17441188 | GENE DELIVERY PARTICLES TO INDUCE TUMOR-DERIVED ANTIGEN PRESENTING CELLS | MARTINEZ, TARA L | 1654 | §103Other | Non-Final OA | 13d | Pending | Sep 20, 2021 |
| 17428848 | EXTERNAL AND INTERNAL INTRAOPERATIVE OPTICAL COHERENCE TOMOGRAPHY IMAGING FOR SUBRETINAL MATERIAL DELIVERY | ROBINSON, NICHOLAS A | 3798 | §103 | Non-Final OA | 8d | Pending | Aug 05, 2021 |
| 17422667 | ADHESIVE/ADSORPTION SWITCH ON NANOPARTICLES TO INCREASE TUMOR UPTAKE AND DELAY TUMOR CLEARANCE | CRAIG, KAILA ANGELIQUE | 1618 | §103 | Non-Final OA | 139d overdue | Pending | Jul 13, 2021 |
| 17416399 | RATIOMETRIC FLUORESCENCE CODING METHOD FOR MULTIPLEX NUCLEIC ACID AMPLIFICATION ASSAYS | TURPIN, ZACHARY MARK | 1682 | §103 | Final Rejection | 38d overdue | Pending | Jun 18, 2021 |
| 17344511 | METHOD FOR MANUFACTURING A LOW-PROFILE INTERCRANIAL DEVICE AND THE LOW-PROFILE INTERCRANIAL DEVICE MANUFACTURED THEREBY | BAHENA, CHRISTIE L. | 3774 | §103 | Final Rejection | 47d | Pending | Jun 10, 2021 |
| 17312916 | HIV SEROSIGNATURES FOR CROSS-SECTIONAL INCIDENCE ESTIMATION | STUART, CAREY ALEXANDER MC | 1671 | §103 | Non-Final OA | 27d | Pending | Jun 10, 2021 |
| 17283217 | USE OF PDE9 INHIBITORS FOR TREATMENT | MOU, LIYUAN | 1628 | §102§103§112 | Non-Final OA | 10d overdue | Pending | Apr 06, 2021 |
| 17194177 | GLP-1R AGONIST AND METHODS OF TREATMENT | HIBBERT, CATHERINE S | 1658 | §103§112 | Non-Final OA | 4d overdue | Pending | Mar 05, 2021 |
| 17189967 | TDP-43 IN DEGENERATIVE DISEASE | STAVROU, CONSTANTINA E | 1632 | §101Other | Final Rejection | 27d | Pending | Mar 02, 2021 |
| 17180696 | NAÏVE HUMAN EMBRYONIC VASCULAR PROGENITOR CELLS AND METHODS OF TREATMENT | GONZALES, JOSEPHINE MARIA | 1631 | §103§112Other | Non-Final OA | — | Pending | Feb 19, 2021 |
| 17265650 | REVERSIBLE LACRIMAL CANALICULAR OCCLUSION DEVICE | DUBOSE, LAUREN | 3771 | §101§103§112 | Final Rejection | 35d | Pending | Feb 03, 2021 |
| 17264222 | COMPETITIVE PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) BINDING AGENTS FOR REDUCTION OF NON-TARGET ORGAN UPTAKE OF RADIOLABELED PSMA INHIBITORS FOR PSMA POSITIVE TUMOR IMAGING AND RADIOPHARMACEUTICAL THERAPY | DONOHUE, SEAN R | 1618 | §102§103Other | Non-Final OA | 34d | Pending | Jan 28, 2021 |
| 17139665 | COMPOSITIONS AND METHODS TO ACCELERATE RESOLUTION OF ACUTE LUNG INFLAMMATION | CRAIGO, BAHAR ALAWI | 1699 | §102§103§112Other | Non-Final OA | — | Pending | Dec 31, 2020 |
| 17123591 | METHODS, SYSTEMS, AND RELATED COMPUTER PROGRAM PRODUCTS FOR EVALUATING CANCER MODEL FIDELITY | KALLAL, ROBERT JAMES | 1685 | §101§112 | Non-Final OA | 15d | Pending | Dec 16, 2020 |
| 17047006 | NON-INVASIVE DETECTION OF RESPONSE TO IMMUNOTHERAPY | HANEY, AMANDA MARIE | 1682 | §103 | Final Rejection | 72d | Pending | Oct 12, 2020 |
| 16979209 | COMPOSITIONS AND METHODS FOR DETECTING MYCOBACTERIUM TUBERCULOSIS | CHEONG, CHEOM-GIL | 1645 | §112 | Non-Final OA | 53d overdue | Pending | Sep 09, 2020 |
| 16971228 | LIQUID BIOPSY METHOD AND DEVICE | MARCSISIN, ELLEN JEAN | 1677 | §103 | Final Rejection | 27d | Pending | Aug 19, 2020 |
| 16933283 | GEOMETRIC BIOPSY PLAN OPTIMIZATION | EDUN, DEAN NAWAAB | 3797 | §103DPOther | Non-Final OA | 61d | Pending | Jul 20, 2020 |
| 16763827 | COMPOSITIONS AND METHODS FOR EFFICIENT GENOME EDITING | WHITEMAN, BRIAN A | 1636 | §102§103§112 | Non-Final OA | 146d overdue | Pending | May 13, 2020 |
| 16758030 | BIOMIMETIC PLATFORMS TO MODEL VASCULAR PATHOPHYSIOLOGY, DIAGNOSTICS, AND THERAPY | WESTON, ALYSSA G | 1633 | §102§103§112 | Non-Final OA | — | Pending | Apr 21, 2020 |
| 16753567 | IMPLANTABLE BIOREACTOR AND METHODS FOR MAKING AND USING SAME | BROWE, DAVID | 1617 | §103§112Other | Non-Final OA | 17d overdue | Pending | Apr 03, 2020 |
| 16753076 | IMAGE TO WORLD REGISTRATION FOR MEDICAL AUGMENTED REALITY APPLICATIONS USING A WORLD SPATIAL MAP | LI, JOHN DENNY | 3798 | §103§112 | Non-Final OA | — | Pending | Apr 02, 2020 |
| 16809496 | METHOD OF IDENTIFYING RISK FOR AUTISM | HANEY, AMANDA MARIE | 1682 | §112 | Final Rejection | 31d overdue | Pending | Mar 04, 2020 |
| 16612035 | DEVICE TO FACILITATE PERFORMING DESCEMET'S MEMBRANE ENDOTHELIAL KERATOPLASTY (DMEK) | DANG, ANH TIEU | 3771 | §102§112 | Non-Final OA | 34d | Pending | Nov 08, 2019 |
| 16556397 | Colorimetric Detection of Organic Amines Using Metal-Organic Frameworks | ADAMS, MICHELLE | 1797 | §102§103§112 | Final Rejection | 70d | Pending | Aug 30, 2019 |
| 16489506 | A NOVEL NERVOUS SYSTEM-SPECIFIC TRANSMEMBRANE PROTEASOME COMPLEX THAT MODULATES NEURONAL SIGNALING THROUGH EXTRACELLULAR SIGNALING VIA BRAIN ACTIVITY PEPTIDES | CHERNYSHEV, OLGA N | 1649 | §112 | Non-Final OA | — | Pending | Aug 28, 2019 |
| 16379763 | IMMORTALIZATION OF CELLS INCLUDING NEURONAL CELLS | DUTT, ADITI | 1675 | §103 | Non-Final OA | — | Pending | Apr 09, 2019 |
| 18293692 | COMPOSITIONS AND METHODS FOR TREATING MELANOMA | LIEB, JEANETTE M | — | §102§103§112 | Non-Final OA | — | Pending | Jan 30, 2024 |
| 18278998 | THERAPEUTIC COMPOSITIONS AND METHODS | CESARE, JOSEPH DAVID | 1675 | §103 | Non-Final OA | — | Pending | Aug 25, 2023 |
| 18364891 | Click chemistry hydrogel with minimal swelling as a dural sealant and local delivery vehicle for recombinant proteins and other bioactive agents | ATKINSON, JOSHUA ALEXANDER | 1612 | §103DP | Non-Final OA | — | Pending | Aug 03, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial